Stem Cell Transplant and Cellular Therapies Symposium 2025: Managing Capacity in the Era of Advanced Therapies

  • Continuing Education
image of cells under a microscope.

Registration Deadline: October 17

Deadline Approaching Enroll now to secure your seat.

Enhance your ability to manage capacity effectively by gaining essential knowledge and strategies to streamline care and improve outcomes for patients undergoing stem cell transplants or CAR T-cell therapies.

  • Live Online or In Person

This course is taught in person and online in real time.

Dana-Farber Cancer Institute, Yawkey Center for Cancer Care, Third Floor Conference Center

$50

This is the standard price, for a full list of profession pricing see below. 
View All

Continuing Education Credits

Earn up to:
6.00 AMA PRA Category 1 Credit(s) ™
6.00 CNE Nursing (ANCC)
View All

One Day

Please view the Schedule for a full description of the program.

On This Page

Overview

This program addresses the critical need to enhance capacity management among healthcare professionals involved in the care of patients receiving stem cell transplants or CAR T-cell therapies. As these advanced cell therapies become increasingly accessible, healthcare providers face challenges in balancing growing patient volumes with limited resources and infrastructure. This course aims to equip clinicians and community partners with the knowledge and strategies needed to optimize capacity, streamline care delivery, and improve outcomes for patients undergoing these complex treatments.

Learning Objectives

  • Summarize the referral process and care coordination between the community oncologist and the transplant team.
  • Summarize the latest advancements in stem cell transplant, immune effector cell therapies, and gene therapies.
  • Identify common and uncommon post-treatment toxicities post-treatment and differentiate between various common, chronic, and advanced infections post-treatment.
  • Learn and create solutions related to capacity management and planning.
  • Review other non-infectious concerns that may present during short-term and long-term recovery from treatment.

Developed and Offered By:

  • Dana-Farber Cancer Institute Logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Dana-Farber Cancer Institute.

Participant Types

Nurses, Nurse Practitioners, Specialty Physicians, Hematology Oncologists, Physician Assistants, Primary Care Physicians, and Social Workers

Schedule

All agenda sessions are in Eastern Time.

Day 1

Friday, October 17, 2025

Breakfast

8:00-9:00 am

Welcome

Amy Browning Emmert; Kidest Mequanent

9:00-9:10 am

The History of Ambulatory Transplant Program at Dana-Farber

Corey Cutler

9:10-10:00 am

How the Evolution of Immune Effector Cell Therapies Impacts Capacity

Kaitlen Reyes; Clifton Mo; Linda Ramsdell

10:00-11:30 am

Lunch Break

11:30 am-12:30 pm

Infectious Disease Management in Transplant and Cell Therapies

Amy Sherman

12:30-1:15 pm

Managing Capacity in Pediatrics

Leslie Lehmann; Colleen Gerrity

1:15-2:00 pm

Break

2:00-2:15 pm

Cellular Therapies Capacity Management & Planning Panel Discussion

John Reagan; Julie Porter; Amy Browning Emmert; Mark Trusheim

2:15-3:15 pm

Cell Manipulation Core Facilities Program (CMCF) Spotlight – History and Effective Approaches to Managing Capacity as a Manufacturer

Sarah Nikiforow; Jose Cancelas

3:15-4:00 pm

Closing Remarks

Kidest Mequanent

4:00-4:10 pm

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

Jose Cancelas, MD
Director of Connell and O'Reilly Families Cell Manipulation Core Facility 

Colleen Gerrity, MSN, RN, CPHON
Nurse Director of Pediatric Oncology, Dana-Farber Cancer Institute 

Caron Jacobson, MD
Medical Director, Immune Effector Cell Therapy Program

Leslie Lehmann, MPH
Clinical Director, Pediatric Stem Cell Transplant Center & Medical Directory for International Hematology Oncology / Bone Marrow Transplant at Boston Children's Hospital

Kidest Mequanent, MHA
Network Manager, Cell Therapies 

Clifton Mo, MD
Director of Autologous Stem Cell Transplantation for Multiple Myeloma

Sarah Nikiforow, MD
Technical Director, Immune Effector Cell Therapy Program

Julie Porter, MS
Vice President, Cellular Therapies Operations

Linda Ramsdell, MSN, FNP-BC, OCN
Assistant Program Director of Immune Effector Cellular Therapy

John Reagan, MD
Hematology Oncologist

Amy Sherman, MD
Instructor, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital and Dana-Farber Cancer Institute 
Research Associate, Precision Vaccines Program, Boston Children’s Hospital

Mark Trusheim, MS
Founder and President of Co-Bio Consulting, LLC & Strategic Director of NEWDIGS at the MIT Center for Biomedical Innovation

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Fee Disclaimer

Dana-Farber Cancer Institute and Mass General Brigham staff are eligible for a registration discount. Contact  kidest_mequanent@dfci.harvard.edu

Role Course Fee
Physician (MD/DO) $50.00
Nurse (RN/APRN) $50.00
PA $50.00
Psychologist $50.00
Resident/Fellow $50.00
Social Worker $50.00
Allied Health Professional / Other $50.00

Dana-Farber Cancer Institute and Mass General Brigham staff are eligible for a registration discount. Contact  kidest_mequanent@dfci.harvard.edu

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Harvard Medical School designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Harvard Medical School designates this Harvard Medical School designates this live activity for a maximum of 6.00 ANCC contact hours.

The National Commission on Certification of Physician Assistants (NCCPA) states that  6.00 AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Provide Patient-Centered Care
  • Work in Interdisciplinary Teams
  • Employ Evidence-Based Practice

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-Based Learning and Improvement

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

Program Topics